Microbiome research may improve menopausal hormone therapy

This research suggests gut and urogenital microbiomes influence menopausal hormone therapy outcomes, potentially reducing side effects for millions of women. The study, from Nature Medicine, advances

This research suggests gut and urogenital microbiomes influence menopausal hormone therapy outcomes, potentially reducing side effects for millions of women. The study, from Nature Medicine, advances both health and broader systems—healthcare access (SUSTENANCE) and shared knowledge infrastructure (THE COMMONS).

While promising, the source material is thin and details remain with the original research. Without verified mechanisms or scale, this remains a potential pathway to better menopausal care rather than an immediate shift in abundance.

Source: Nature Medicine